Last of the Tasmanian devils? Infectious cancer to blame

submitted by: nsf

Researcher Andrew Storfer discusses his research on Tasmanian devils, their infectious cancer, and how this research has wide reaching impacts.

Tasmanian devils' infectious cancer offer insights into human epidemics

submitted by: nsf

What can we learn about diseases by studying the Tasmanian devils' infectious cancer? Sam Scheiner of the NSF discusses the insight that science can learn by studying these critters.

Visit NSF.gov for more information...
http://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=129508

Credit: NSF

Appendix cancer – alternatives to surgery

submitted by: mdanderson
Download from itunes: https://itunes.apple.com/us/itunes-u/appendix-cancer-alternatives/id4318... . If appendix cancer is found early, surgery is the standard of care. Alternatives to surgery are available for advanced appendix cancer, but more data is needed to accurately treat this rare form of cancer. Cathy Eng, M.D., associate professor of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, discusses options for non-surgical candidates including hyperthermic...

MWV Episode 80 - Harald zur Hausen - Human Papilloma Virus (HPV)

submitted by: MicrobeWorld
Vincent Racaniello speaks with Professor Harald zur Hausen, recipient of the 2013 Society for General Microbiology Prize Medal for "work that has had a far-reaching impact beyond microbiology." Professor zur Hausen talks about the beginnings of his work on the human papilloma virus (HPV) starting in 1972 with a group he setup to look at the "isolation and characterization of the viruses in genital warts." This group would lead to the discovery of HPV 16 and 18 (the leading cause of...

First-year progress in MD Anderson’s Moon Shots Program

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 announced its Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program initially targets acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung cancer; melanoma; prostate cancer; and triple-negative breast and high-grade serious ovarian cancers....

Chronic Lymphocytic Leukemia CLL Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveres into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Michael Keating, M.D., professor in MD Anderson's Leukemia...